Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.

Lee JK, Merchant SA, Schneider JL, Jensen CD, Fireman BH, Quesenberry CP, Corley DA.

Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000591. [Epub ahead of print]

PMID:
32205645
2.

Natural Language Processing for the Accurate Identification of Colorectal Cancer Mismatch Repair Status in Lynch Syndrome Screening.

Li D, Udaltsova N, Layefsky E, Doan C, Corley DA.

Clin Gastroenterol Hepatol. 2020 Feb 7. pii: S1542-3565(20)30119-1. doi: 10.1016/j.cgh.2020.01.040. [Epub ahead of print]

PMID:
32036042
3.

Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer.

Archambault AN, Su YR, Jeon J, Thomas M, Lin Y, Conti DV, Win AK, Sakoda LC, Lansdorp-Vogelaar I, Peterse EFP, Zauber AG, Duggan D, Holowatyj AN, Huyghe JR, Brenner H, Cotterchio M, Bézieau S, Schmit SL, Edlund CK, Southey MC, MacInnis RJ, Campbell PT, Chang-Claude J, Slattery ML, Chan AT, Joshi AD, Song M, Cao Y, Woods MO, White E, Weinstein SJ, Ulrich CM, Hoffmeister M, Bien SA, Harrison TA, Hampe J, Li CI, Schafmayer C, Offit K, Pharoah PD, Moreno V, Lindblom A, Wolk A, Wu AH, Li L, Gunter MJ, Gsur A, Keku TO, Pearlman R, Bishop DT, Castellví-Bel S, Moreira L, Vodicka P, Kampman E, Giles GG, Albanes D, Baron JA, Berndt SI, Brezina S, Buch S, Buchanan DD, Trichopoulou A, Severi G, Chirlaque MD, Sánchez MJ, Palli D, Kühn T, Murphy N, Cross AJ, Burnett-Hartman AN, Chanock SJ, de la Chapelle A, Easton DF, Elliott F, English DR, Feskens EJM, FitzGerald LM, Goodman PJ, Hopper JL, Hudson TJ, Hunter DJ, Jacobs EJ, Joshu CE, Küry S, Markowitz SD, Milne RL, Platz EA, Rennert G, Rennert HS, Schumacher FR, Sandler RS, Seminara D, Tangen CM, Thibodeau SN, Toland AE, van Duijnhoven FJB, Visvanathan K, Vodickova L, Potter JD, Männistö S, Weigl K, Figueiredo J, Martín V, Larsson SC, Parfrey PS, Huang WY, Lenz HJ, Castelao JE, Gago-Dominguez M, Muñoz-Garzón V, Mancao C, Haiman CA, Wilkens LR, Siegel E, Barry E, Younghusband B, Van Guelpen B, Harlid S, Zeleniuch-Jacquotte A, Liang PS, Du M, Casey G, Lindor NM, Le Marchand L, Gallinger SJ, Jenkins MA, Newcomb PA, Gruber SB, Schoen RE, Hampel H, Corley DA, Hsu L, Peters U, Hayes RB.

Gastroenterology. 2020 Apr;158(5):1274-1286.e12. doi: 10.1053/j.gastro.2019.12.012. Epub 2019 Dec 19.

PMID:
31866242
4.

Promises and Potential Pitfalls of Shared Decision Making in Cancer Screening.

Haug U, Senore C, Corley DA.

Gastroenterology. 2020 Mar;158(4):802-805. doi: 10.1053/j.gastro.2019.11.293. Epub 2019 Dec 5. No abstract available.

PMID:
31812511
5.

Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.

Callahan CL, Schwartz K, Corley DA, Ruterbusch JJ, Zhao WK, Shuch B, Graubard BI, Rothman N, Chow WH, Silverman DT, Purdue MP, Hofmann JN.

Cancer Causes Control. 2020 Jan;31(1):85-93. doi: 10.1007/s10552-019-01248-1. Epub 2019 Nov 28.

PMID:
31782041
6.

Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Xie SH, Fang R, Huang M, Dai J, Thrift AP, Anderson LA, Chow WH, Bernstein L, Gammon MD, Risch HA, Shaheen NJ, Reid BJ, Wu AH, Iyer PG, Liu G, Corley DA, Whiteman DC, Caldas C, Pharoah PD, Hardie LJ, Fitzgerald RC, Shen H, Vaughan TL, Lagergren J.

Clin Gastroenterol Hepatol. 2019 Nov 19. pii: S1542-3565(19)31317-5. doi: 10.1016/j.cgh.2019.11.030. [Epub ahead of print]

PMID:
31756444
7.

Incidence rates of cardiovascular outcomes in a community-based population of cancer patients.

Masson R, Titievsky L, Corley DA, Zhao W, Lopez AR, Schneider J, Zaroff JG.

Cancer Med. 2019 Dec;8(18):7913-7923. doi: 10.1002/cam4.2657. Epub 2019 Oct 30.

8.

Morbidity and Mortality After Surgery for Nonmalignant Colorectal Polyps: A 10-Year Nationwide Analysis.

Ma C, Teriaky A, Sheh S, Forbes N, Heitman SJ, Jue TL, Munroe CA, Jairath V, Corley DA, Lee JK.

Am J Gastroenterol. 2019 Nov;114(11):1802-1810. doi: 10.14309/ajg.0000000000000407.

9.

Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.

Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, Kamineni AS, Schottinger JE, Ghai NR, Udaltsova N, Zhao WK, Fireman BH, Quesenberry CP, Orav EJ, Skinner CS, Halm EA, Corley DA.

Gastroenterology. 2020 Mar;158(4):884-894.e5. doi: 10.1053/j.gastro.2019.09.039. Epub 2019 Oct 4.

PMID:
31589872
10.

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.

Helsingen LM, Vandvik PO, Jodal HC, Agoritsas T, Lytvyn L, Anderson JC, Auer R, Murphy SB, Almadi MA, Corley DA, Quinlan C, Fuchs JM, McKinnon A, Qaseem A, Heen AF, Siemieniuk RAC, Kalager M, Usher-Smith JA, Lansdorp-Vogelaar I, Bretthauer M, Guyatt G.

BMJ. 2019 Oct 2;367:l5515. doi: 10.1136/bmj.l5515.

11.

Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium.

Burnett-Hartman AN, Kamineni A, Corley DA, Singal AG, Halm EA, Rutter CM, Chubak J, Lee JK, Doubeni CA, Inadomi JM, Doria-Rose VP, Zheng Y.

EGEMS (Wash DC). 2019 Aug 2;7(1):37. doi: 10.5334/egems.296.

12.

Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.

Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB.

Cancer. 2019 Dec 1;125(23):4210-4223. doi: 10.1002/cncr.32444. Epub 2019 Sep 6.

PMID:
31490550
13.

Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network.

Burnett-Hartman AN, Udaltsova N, Kushi LH, Neslund-Dudas C, Rahm AK, Pawloski PA, Corley DA, Knerr S, Feigelson HS, Hunter JE, Tabano DC, Epstein MM, Honda SA, Ter-Minassian M, Lynch JA, Lu CY.

JCO Clin Cancer Inform. 2019 Sep;3:1-10. doi: 10.1200/CCI.19.00026.

14.

Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.

Selby K, Levine EH, Doan C, Gies A, Brenner H, Quesenberry C, Lee JK, Corley DA.

Gastroenterology. 2019 Dec;157(6):1494-1505. doi: 10.1053/j.gastro.2019.08.023. Epub 2019 Aug 22.

PMID:
31472152
15.

Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth.

Corley DA.

Gastroenterology. 2019 Sep;157(3):604-607. doi: 10.1053/j.gastro.2019.07.039. Epub 2019 Jul 30. No abstract available.

PMID:
31378636
16.

Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.

Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA.

J Natl Cancer Inst. 2020 Mar 1;112(3):238-246. doi: 10.1093/jnci/djz137.

PMID:
31292633
17.

Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting.

Lam JO, Hurley LB, Udaltsova N, Alexeeff SE, Klein DB, Corley DA, Silverberg MJ.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):284-291. doi: 10.1097/QAI.0000000000002024.

PMID:
31194703
18.

Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.

Li D, Hoodfar E, Jiang SF, Udaltsova N, Pham NP, Jodesty Y, Armstrong MA, Hung YY, Baker RJ, Postlethwaite D, Ladabaum U, Levin TR, Corley DA, Bergoffen J.

Ann Intern Med. 2019 Jul 2;171(1):19-26. doi: 10.7326/M18-3316. Epub 2019 Jun 11.

PMID:
31181578
19.

Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection.

Selby K, Levin TR, Corley DA.

Ann Intern Med. 2019 May 21;170(10):736-737. doi: 10.7326/L19-0095. No abstract available.

PMID:
31108529
20.

Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network.

Burnett-Hartman AN, Powers JD, Chubak J, Corley DA, Ghai NR, McMullen CK, Pawloski PA, Sterrett AT, Feigelson HS.

Cancer Causes Control. 2019 Jul;30(7):747-755. doi: 10.1007/s10552-019-01181-3. Epub 2019 May 17.

PMID:
31102084
21.

Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.

Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, Garcia M, Chubak J, Doubeni C, Quinn VP, Haas JS, Li CI, Wernli KJ, Klabunde CN; PROSPR consortium.

Am J Prev Med. 2019 May;56(5):e143-e152. doi: 10.1016/j.amepre.2019.01.005.

PMID:
31003603
22.

Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network.

Doria-Rose VP, Greenlee RT, Buist DSM, Miglioretti DL, Corley DA, Brown JS, Clancy HA, Tuzzio L, Moy LM, Hornbrook MC, Brown ML, Ritzwoller DP, Kushi LH, Greene SM.

EGEMS (Wash DC). 2019 Mar 29;7(1):7. doi: 10.5334/egems.273. Review.

23.

Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus?

Fitzgerald RC, Corley DA.

Gastroenterology. 2019 Apr;156(5):1228-1231. doi: 10.1053/j.gastro.2019.03.001. Epub 2019 Mar 5. No abstract available.

PMID:
30849313
24.

Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study.

Selby K, Jensen CD, Zhao WK, Lee JK, Slam A, Schottinger JE, Bacchetti P, Levin TR, Corley DA.

Clin Transl Gastroenterol. 2019 Feb;10(2):e00010. doi: 10.14309/ctg.0000000000000010.

25.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2227-2235.e1. doi: 10.1016/j.cgh.2019.01.041. Epub 2019 Feb 1.

PMID:
30716477
26.

Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.

Tayob N, Christie I, Richardson P, Feng Z, White DL, Davila J, Corley DA, Kanwal F, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1886-1893.e5. doi: 10.1016/j.cgh.2018.12.005. Epub 2018 Dec 14.

PMID:
30557738
27.

Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings.

Lee JK, Jensen CD, Levin TR, Zauber AG, Schottinger JE, Quinn VP, Udaltsova N, Zhao WK, Fireman BH, Quesenberry CP, Doubeni CA, Corley DA.

JAMA Intern Med. 2019 Feb 1;179(2):153-160. doi: 10.1001/jamainternmed.2018.5565.

28.

Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems.

Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF; PROSPR consortium.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):91-98. doi: 10.1158/1055-9965.EPI-18-0452. Epub 2018 Nov 20.

29.

Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.

Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Paul Doria-Rose V; PROSPR consortium.

Int J Cancer. 2019 Mar 15;144(6):1460-1473. doi: 10.1002/ijc.31940. Epub 2018 Dec 20.

30.

Gastroenterology's Improvements and New Features.

Corley DA, Peek RM Jr, Lowe C, Brounstein L, Landis E.

Gastroenterology. 2018 Nov;155(5):1290-1292. doi: 10.1053/j.gastro.2018.10.005. Epub 2018 Oct 6. No abstract available.

PMID:
30300612
31.

Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.

Doubeni CA, Fedewa SA, Levin TR, Jensen CD, Saia C, Zebrowski AM, Quinn VP, Rendle KA, Zauber AG, Becerra-Culqui TA, Mehta SJ, Fletcher RH, Schottinger J, Corley DA.

Gastroenterology. 2019 Jan;156(1):63-74.e6. doi: 10.1053/j.gastro.2018.09.040. Epub 2018 Sep 27.

32.

Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study.

Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA.

Ann Intern Med. 2018 Oct 2;169(7):439-447. doi: 10.7326/M18-0244. Epub 2018 Sep 18.

33.

Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening.

Ghai NR, Jensen CD, Corley DA, Doubeni CA, Schottinger JE, Zauber AG, Lee AT, Contreras R, Levin TR, Lee JK, Quinn VP.

Clin Transl Gastroenterol. 2018 Sep 21;9(9):186. doi: 10.1038/s41424-018-0051-2.

34.

When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages.

Corley DA, Peek RM Jr.

Gastroenterology. 2018 Oct;155(4):947-949. doi: 10.1053/j.gastro.2018.08.040. Epub 2018 Sep 4. No abstract available.

35.

Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers.

Tollivoro TA, Jensen CD, Marks AR, Zhao WK, Schottinger JE, Quinn VP, Ghai NR, Zauber AG, Doubeni CA, Levin TR, Fireman B, Quesenberry CP, Corley DA.

Gastrointest Endosc. 2019 Jan;89(1):168-176.e3. doi: 10.1016/j.gie.2018.08.023. Epub 2018 Aug 23.

PMID:
30144415
36.

Overdiagnosis in Colorectal Cancer Screening: Time to Acknowledge a Blind Spot.

Kalager M, Wieszczy P, Lansdorp-Vogelaar I, Corley DA, Bretthauer M, Kaminski MF.

Gastroenterology. 2018 Sep;155(3):592-595. doi: 10.1053/j.gastro.2018.07.037. Epub 2018 Aug 1. No abstract available.

PMID:
30076834
37.

Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.

Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, Lee JK, Zhao WK, Udaltsova N, Ghai NR, Lee AT, Quesenberry CP, Fireman BH, Doubeni CA.

Gastroenterology. 2018 Nov;155(5):1383-1391.e5. doi: 10.1053/j.gastro.2018.07.017. Epub 2018 Jul 19.

38.

Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.

Callahan CL, Hofmann JN, Corley DA, Zhao WK, Shuch B, Chow WH, Purdue MP.

Cancer Epidemiol. 2018 Oct;56:31-37. doi: 10.1016/j.canep.2018.07.002. Epub 2018 Jul 18.

39.

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.

Rutter MD, Beintaris I, Valori R, Chiu HM, Corley DA, Cuatrecasas M, Dekker E, Forsberg A, Gore-Booth J, Haug U, Kaminski MF, Matsuda T, Meijer GA, Morris E, Plumb AA, Rabeneck L, Robertson DJ, Schoen RE, Singh H, Tinmouth J, Young GP, Sanduleanu S.

Gastroenterology. 2018 Sep;155(3):909-925.e3. doi: 10.1053/j.gastro.2018.05.038. Epub 2018 Jun 27.

40.

Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey.

McMullen C, Bulkley J, Corley DA, Madrid S, Davis AQ, Hesselbrock R, Kurtilla F, Anderson CK, Arterburn D, Somkin CP, Pawloski PA, Ghai NR, Feigelson HS.

Support Care Cancer. 2019 Jan;27(1):147-156. doi: 10.1007/s00520-018-4299-6. Epub 2018 Jun 12.

41.

Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, El-Serag HB, Rubenstein JH, Thrift AP.

Am J Gastroenterol. 2018 Aug;113(8):1148-1155. doi: 10.1038/s41395-018-0070-3. Epub 2018 Jun 8.

PMID:
29880962
42.

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.

Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K.

CA Cancer J Clin. 2018 May;68(3):199-216. doi: 10.3322/caac.21452. Epub 2018 Mar 30.

43.

Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) Consortium, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1598-1606.e4. doi: 10.1016/j.cgh.2018.03.007. Epub 2018 Mar 15.

44.

Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.

Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA.

Am J Gastroenterol. 2018 May;113(5):746-754. doi: 10.1038/s41395-018-0023-x. Epub 2018 Feb 27.

45.

Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.

Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) consortium, Whiteman DC, Vaughan TL, Thrift AP.

Gastroenterology. 2018 Apr;154(5):1273-1281.e3. doi: 10.1053/j.gastro.2017.12.003. Epub 2017 Dec 13.

46.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17.

47.

The 75th Diamond Anniversary of Gastroenterology: 1943-2018.

Peek RM, Corley DA.

Gastroenterology. 2018 Jan;154(1):1-5. doi: 10.1053/j.gastro.2017.10.019. Epub 2017 Nov 9. No abstract available.

PMID:
29128318
48.

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review.

Selby K, Baumgartner C, Levin TR, Doubeni CA, Zauber AG, Schottinger J, Jensen CD, Lee JK, Corley DA.

Ann Intern Med. 2017 Oct 17;167(8):565-575. doi: 10.7326/M17-1361. Epub 2017 Oct 10. Review.

49.

Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing.

Lee JK, Jensen CD, Levin TR, Zauber AG, Doubeni CA, Zhao WK, Corley DA.

J Clin Gastroenterol. 2019 Jan;53(1):e25-e30. doi: 10.1097/MCG.0000000000000929.

50.

Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis.

Li N, Petrick JL, Steck SE, Bradshaw PT, McClain KM, Niehoff NM, Engel LS, Shaheen NJ, Corley DA, Vaughan TL, Gammon MD.

Eur J Epidemiol. 2017 Nov;32(11):1007-1017. doi: 10.1007/s10654-017-0301-8. Epub 2017 Sep 1.

Supplemental Content

Loading ...
Support Center